Suven's Pashamylaram unit receives US FDA nod

Suven Life Sciences Ltd’s facility in Pashamylaram near Hyderabad has received approval from the US Food and Drug Administration (FDA) for manufacture and supply of active pharmaceutical ingredients (APIs), intermediates and formulations. The company has undergone US FDA renewal inspection at its Pashamylaram facility recently.
 
Suven Life Sciences has so far filed 29 Drug Master Files (DMFs) and 1 Abbreviated New Drug Application (ANDA) from this facility which is FDA complaint under current good manufacturing practices (cGMP) and continued after renewal inspection.